Sign In
Buy BCEL
$0.0900
+0 (+0%)
At Close: Sep 13, 2024
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
11:19am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
Atreca (BCEL) Receives a Buy from Canaccord Genuity
10:31am, Thursday, 30'th Apr 2020
Canaccord Genuity analyst John Newman maintained a Buy rating on Atreca (BCEL – Research Report) yesterday and set a price
Coronavirus: ‘One billion’ around the world could become infected- report
04:22pm, Tuesday, 28'th Apr 2020
One billion people could become infected with the coronavirus worldwide unless vulnerable countries are given urgent help, an aid group has warned. The International Rescue Committee (IRC) said fin…
Coronavirus could kill more than 3 million people in vulnerable and poor countries, aid group says
04:04pm, Tuesday, 28'th Apr 2020
Existing humanitarian crises like political and economic instability combined with the Covid-19 crisis could create a "double emergency" for vulnerable countries, IRC warns.
Coronavirus: Horror stats show 'ONE BILLION people in 34 countries will catch virus'
11:01pm, Monday, 27'th Apr 2020
CORONAVIRUS has disrupted the way in which modern life is carried out, while devastating huge swathes of populations as thousands succumb to the deadly virus.
Wednesday's top analyst upgrades and downgrades included Boston Scientific, Chipotle Mexican Grill, Coca-Cola, Darden Restaurants, Home Depot, Netflix, Snap, Tesla, Transocean and Zynga.
BofA likes Johnson & Johnson in premarket analyst action
11:38am, Wednesday, 22'nd Apr 2020
Adaptimmune (NASDAQ:ADAP) initiated with Neutral rating and $3 (17% downside risk) price target at Mizuho Securities.Autolus Therapeutics (NASDAQ:AUTL) initiated with Buy rating and $18 (90% upside) p
Ventilator shame: Horror statistics show 'dire' ICU numbers in devastated battle zones
02:24pm, Monday, 20'th Apr 2020
THE devastating impact of the killer coronavirus on some of the world's most prosperous countries has exposed key flaws in wealthy nations and their health systems - but the real damage on countries e
Atreca (NASDAQ:BCEL) Insider Norman Michael Greenberg Sells 5,000 Shares
09:42am, Saturday, 18'th Apr 2020
Atreca (NASDAQ:BCEL) insider Norman Michael Greenberg sold 5,000 shares of Atreca stock in a transaction that occurred on Tuesday, April 14th. The stock was sold at an average price of $18.00, for a t
Atreca (NASDAQ:BCEL) Now Covered by Robert W. Baird
09:18am, Friday, 17'th Apr 2020
Robert W. Baird initiated coverage on shares of Atreca (NASDAQ:BCEL) in a report released on Wednesday, MarketBeat.com reports. The firm set an “outperform” rating and a $30.00 price target on the
Atreca (NASDAQ:BCEL) Receives Consensus Rating of "Buy" from Analysts
09:54am, Thursday, 16'th Apr 2020
Atreca (NASDAQ:BCEL) has received an average recommendation of “Buy” from the ten analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold ra
Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
12:35pm, Saturday, 11'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Greece horror: How coronavirus spread is EIGHT times faster in camps than Diamond Princess
11:13am, Saturday, 11'th Apr 2020
GREECE could see the deadly coronavirus sweep through its destitute and overcrowded refugee camps eight times faster than the bug went through holidaymakers on the ill-fated Diamond Princess cruise sh
The Hill's Coronavirus Report: David Miliband says world won't be safe until poor nations get more aid; Cuomo rips WHO
07:25pm, Friday, 10'th Apr 2020
WHAT YOU NEED TO KNOW TODAY > Global coronavirus deaths pass 100,000> Trump downplays widespread testing before reopening economy > Surgeon general says most of U.S. won’t be ready to open by May >
Goldman Sachs Group Inc. Boosts Stock Position in Atreca (NASDAQ:BCEL)
10:42am, Wednesday, 08'th Apr 2020
Goldman Sachs Group Inc. boosted its holdings in shares of Atreca (NASDAQ:BCEL) by 7.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Com
